191 related articles for article (PubMed ID: 30446119)
1. Polymeric fluorescent heparin as one-step FRET substrate of human heparanase.
Sistla JC; Morla S; Alabbas AB; Kalathur RC; Sharon C; Patel BB; Desai UR
Carbohydr Polym; 2019 Feb; 205():385-391. PubMed ID: 30446119
[TBL] [Abstract][Full Text] [Related]
2. A Robust, One-step FRET Assay for Human Heparanase.
Sistla JC; Desai UR
Bio Protoc; 2019 Sep; 9(17):e3356. PubMed ID: 33654855
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase.
Pala D; Rivara S; Mor M; Milazzo FM; Roscilli G; Pavoni E; Giannini G
Glycobiology; 2016 Jun; 26(6):640-54. PubMed ID: 26762172
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
[TBL] [Abstract][Full Text] [Related]
5. Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin.
Elli S; Guerrini M
Adv Exp Med Biol; 2020; 1221():169-188. PubMed ID: 32274710
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
[TBL] [Abstract][Full Text] [Related]
7. Development of new methods for determining the heparanase enzymatic activity.
Melo CM; Tersariol IL; Nader HB; Pinhal MA; Lima MA
Carbohydr Res; 2015 Aug; 412():66-70. PubMed ID: 26062789
[TBL] [Abstract][Full Text] [Related]
8. Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase).
Gandhi NS; Freeman C; Parish CR; Mancera RL
Glycobiology; 2012 Jan; 22(1):35-55. PubMed ID: 21746763
[TBL] [Abstract][Full Text] [Related]
9. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
10. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
Irimura T; Nakajima M; Nicolson GL
Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
12. Identification of protease inhibitors by a fast fluorimetric assay.
Doti N; Raimondo D; Sabatella M; Ruvo M
Mol Biotechnol; 2013 Jun; 54(2):283-91. PubMed ID: 22684771
[TBL] [Abstract][Full Text] [Related]
13. A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease.
Gratz A; Götz C; Jose J
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):234-9. PubMed ID: 19874207
[TBL] [Abstract][Full Text] [Related]
14. An ultrasensitive FRET-based fluorescent low molecular weight heparin nanoprobe for quantifying heparanase activity.
Gu Y; Peng L; Ding W; Wang Y; Zeng X
Talanta; 2023 Mar; 254():124207. PubMed ID: 36549136
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatographic enzymatic studies with on-line Beta-secretase immobilized enzyme reactor and 4-(4-dimethylaminophenylazo) benzoic acid/5-[(2-aminoethyl) amino] naphthalene-1-sulfonic acid peptide as fluorogenic substrate.
De Simone A; Seidl C; Santos CA; Andrisano V
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():108-14. PubMed ID: 24590190
[TBL] [Abstract][Full Text] [Related]
16. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
Savion N; Disatnik MH; Nevo Z
J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
[TBL] [Abstract][Full Text] [Related]
17. Non-Anticoagulant Heparins as Heparanase Inhibitors.
Cassinelli G; Torri G; Naggi A
Adv Exp Med Biol; 2020; 1221():493-522. PubMed ID: 32274724
[TBL] [Abstract][Full Text] [Related]
18. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard.
Chhabra M; Ferro V
Molecules; 2018 Nov; 23(11):. PubMed ID: 30441818
[TBL] [Abstract][Full Text] [Related]
19. Heparanase neutralizes the anticoagulation properties of heparin and low-molecular-weight heparin.
Nasser NJ; Sarig G; Brenner B; Nevo E; Goldshmidt O; Zcharia E; Li JP; Vlodavsky I
J Thromb Haemost; 2006 Mar; 4(3):560-5. PubMed ID: 16460439
[TBL] [Abstract][Full Text] [Related]
20. Development of both colorimetric and fluorescence heparinase activity assays using fondaparinux as substrate.
Schiemann S; Lühn S; Alban S
Anal Biochem; 2012 Aug; 427(1):82-90. PubMed ID: 22579846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
